Higher S100B levels predict persistently elevated anhedonia with escitalopram monotherapy versus antidepressant combinations: Findings from CO-MED trial

Manish K Jha, Abu Minhajuddin, Bharathi Gadad, Cherise Chin Fatt, Madhukar H. Trivedi

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'Higher S100B levels predict persistently elevated anhedonia with escitalopram monotherapy versus antidepressant combinations: Findings from CO-MED trial'. Together they form a unique fingerprint.

Medicine & Life Sciences